Tryptophan hydroxylase (TPH) is the rate-limiting enzyme in the biosynthesis of serotonin, a neurotransmitter centrally implicated in mood regulation and affective disorders. Two isoforms, TPH1 and ...
Some evidence suggests that L-tryptophan supplements may help to treat conditions such as anxiety and sleep disorders. However, more research into the safety and efficacy of L-tryptophan supplements ...
In conjunction with preliminary studies on monoamine oxidase inhibitors and epilepsy 4 we have recently observed that ingestion of L-tryptophan can in itself produce significant Central-nervous-system ...
TPH2 genetic variance in rhesus monkeys may mimic in effect the variance with orthologous human alleles that, although likely consisting of different polymorphisms than occur in humans, nevertheless ...
The amino acids 5-hydroxytryptophan (5-HTP) and l-tryptophan are precursors of serotonin. 5-HTP is generally recommended over l-tryptophan because it crosses the blood-brain barrier at a higher rate, ...
Preliminary studies suggested that telotristat ethyl, a tryptophan hydroxylase inhibitor, reduces bowel movement (BM) frequency in patients with carcinoid syndrome. This placebo-controlled phase III ...
TPT-004, a tryptophan hydroxylase inhibitor with efficacy in MC38 mouse colon carcinoma model Dec. 4, 2023 ...
L-tryptophan is an essential amino acid that helps the body make proteins and certain brain-signaling chemicals. Your body changes L-tryptophan into a brain chemical called serotonin. Serotonin helps ...
Tryptophan is an amino acid. Amino acids are molecules that your body uses to make proteins, which help you to: Tryptophan plays a part in many aspects of your health. For instance, it helps keep your ...
The amino acids 5-hydroxytryptophan (5-HTP) and l-tryptophan are precursors of serotonin. 5-HTP is generally recommended over l-tryptophan because it crosses the blood-brain barrier at a higher rate, ...
Preliminary studies suggested that telotristat ethyl, a tryptophan hydroxylase inhibitor, reduces bowel movement (BM) frequency in patients with carcinoid syndrome. This placebo-controlled phase III ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results